In Brief

AstraZeneca delivery delays threatens EU’s Covid vaccination target

Fresh setback to bloc’s bid to inoculate 70% of adults by summer

EU officials battling to boost the bloc’s floundering Covid vaccine rollout have reacted with fury after being warned of delays to deliveries of AstraZeneca’s jabs. 

An insider told Politico’s Brussels Playbook that “serious questions” had been raised in the European Commission following the Cambridge-based drugmaker’s announcement that deliveries will be “lower than initially anticipated” owing to “reduced yields at a manufacturing site within our European supply chain”.

European Council President Charles Michel has warned that failing to meet the delivery deadlines agreed in a deal signed last year will mean the bloc’s target of vaccinating 70% of the adult population of EU countries by summer will be “difficult” to fulfil.

“There are difficulties in the production lines in the coming weeks and that will make the process more complex,” Michel told France’s Europe 1 radio.

The EU signed up to a “three-digit million-euro” contract with the drugmaker to reserve 300 million vaccine doses, with an option for an additional 100 million, according to documents published by the European Commission.  

In light of the delivery delays announcement, what the EU wants to know now “is quite simple: what the problem is”, says Brussels Playbook’s Florian Eder

Brussels is convinced that “either the advance production hasn’t happened, or vaccines have been produced but sold to someone else that perhaps agreed to pay more”, Eder continues. “Either way, the company has opted to not honour an agreement made with a huge market of 27 countries and 450 million people, perhaps a risky choice.”

The bloc can ill afford further problems with its vaccination programme, amid widespread anger over existing shortages of jabs and frustration over delays in giving vaccines regulatory approval.

An analysis by the Financial Times found that EU countries have administered an average of around only two doses per 100 residents, compared with more than ten doses per 100 in the UK.

“The widening gap has sparked growing anxiety in European capitals”, where officials said the bloc would hold talks with AstraZeneca today “in an effort to speed up production”, the paper reports.

Recommended

What will the next global pandemic look like?
Ebola
Today’s big question

What will the next global pandemic look like?

‘More than 300,000 housebound yet to get booster jabs’
Today's newspaper front pages
Today’s newspapers

‘More than 300,000 housebound yet to get booster jabs’

Crypto-positivity, Barbados and a 3D-printed eye
Koh Samui, Thailand
Podcast

Crypto-positivity, Barbados and a 3D-printed eye

Covid this Christmas: the advice from experts and the government
Boris Johnson in front of a Christmas tree
Between the lines

Covid this Christmas: the advice from experts and the government

Popular articles

Is Boris Johnson’s authority ‘evaporating’?
Boris Johnson
Behind the scenes

Is Boris Johnson’s authority ‘evaporating’?

Is World War Three looming?
Xi Jinping
In Depth

Is World War Three looming?

Vladimir Putin and his mysterious love life
Vladimir Putin and his now ex-wife Lyudmila Putina
Profile

Vladimir Putin and his mysterious love life

The Week Footer Banner